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A vision for improved cancer screening in Nigeria
As the global burden of disease shifts from infectious 
diseases to non-communicable diseases (NCDs), 
cancer has increasingly become a major contributor to 
morbidity and mortality in low-income and middle-
income countries (LMICs). Major reasons for these shifts 
include increasing life expectancy and changing diets 
and lifestyles. An estimated 14·1 million new cases and 
8·2 million cancer deaths occurred worldwide in 2012, 
with more than 65% of cancer deaths occurring in 
LMICs.1 In Nigeria, cervical cancer and breast cancer are 
two of the leading causes of cancer deaths in women, 
accounting for more than 40% of all women’s cancer 
and about two-thirds of cancer deaths.2,3 Despite this, 
cancer screening eﬀ orts lag behind other priorities and 
resources available for cancer care are insuﬃ  cient. 
Because of an absence of information and poor 
access to health, most women in Nigeria are diagnosed 
at advanced disease stages, resulting in restricted 
treatment options and high mortality rates. These poor 
outcomes are largely attributable to patient and systems 
barriers in the form of poor education and awareness, 
ﬁ nancial barriers, shortage of health workers, limited 
health infrastructure, poor management and planning, 
inequity in resource distribution, and access to care.4,5 
Various innovative opportunities exist to reduce 
the morbidity and mortality associated with cervical 
cancer and breast cancer in Nigeria without aﬀ ecting 
other key health and development priorities. Resources 
designated for cancer care will be most eﬀ ective if they 
strengthen primary care and the entire health system 
and are integrated into platforms already in place for 
other diseases.4 Integrating cervical and breast cancer 
screening services into existing delivery platforms for 
sexual, reproductive, and maternal health services has 
been proposed as an eﬀ ective and eﬃ  cient strategy.6,7 
Such integration could address women’s multiple 
needs at once, potentially increase cervical and breast 
cancer screening, and, ultimately, reduce morbidity 
and mortality.
Family planning, prenatal, postnatal, and HIV 
treatment clinics provide ample opportunities for 
contact with women in the reproductive age group 
who might have little knowledge of cervical and breast 
cancer issues. At these clinics, tailored educational 
messages on breast and cervical cancer can be included 
in these visits to address gaps in knowledge and correct 
myths and misconceptions. Emphasis must be placed 
on early detection to reduce the proportion of women 
diagnosed in late stages. 
Cervical cancer prevention strategies that include 
human papillomavirus (HPV) vaccination and visual 
inspection with acetic acid and same-visit cryotherapy (so-
called screen-and-treat) are cost-eﬀ ective and accessible 
alternatives to the cytology-based screening programmes9 
that are currently in place in many health centres in 
Nigeria. The demonstration project on cervical cancer 
prevention through screening using visual inspection 
with acetic acid and treatment with cryotherapy done in 
six African countries including Nigeria showed that the 
screen and treat approach is acceptable and feasible and 
can be introduced into existing sexual and reproductive 
health services.10 Through scale up and integration of such 
programmes into primary health centres in all 774 local 
governments in Nigeria, the Nigerian Government could 
facilitate the extension of cancer screening services to 
hard to reach populations.
Although mammography remains the gold standard 
for early detection of breast cancer,11 it is cost prohibitive 
and not readily accessible to a lot of women in Nigeria 
who live below the poverty line. The Breast Health 
Global Initiative (BHGI) resource stratiﬁ ed guidelines 
recommend clinical breast examination as a practical 
and necessary alternative for early detection in low-
resource settings.12 Training of front-line health providers 
in visual inspection with acetic acid and clinical breast 
examination as a screening method for cervical and 
breast cancer and appropriate referral linkages increases 
the chances of detection of both cancers at an early stage.
Currently a major initiative focused on cervical cancer 
screening and treatment for women in Nigeria is funded 
by the Bill & Melinda  Gates foundation in partnership 
with Marie Stopes International, the International 
Planned Parenthood Federation, Population Services 
International, and Society for Family Health.13 However, 
Nigeria needs to integrate more creative and innovative 
partnerships for early detection of cervical and breast 
cancer being implemented in diﬀ erent low-resource 
settings. The Pink Ribbon Red Ribbon Initiative, a 
public–private partnership, operates as a country-
aligned partnership with sub-Saharan African countries 
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to reduce the burden of breast and cervical cancer using 
health platforms established for HIV/AIDS screening 
and treatment.14 These partnerships and collaborations 
provide an excellent opportunity to expand the 
availability of cervical and breast cancer services. 
Nigeria developed a national cancer control plan 
in 2008, but implementation has been suboptimal.15 
Nigeria is in a prime position to take on a leadership role 
in improving cancer screening for the African continent 
by implementing policies and relatively inexpensive 
programmes for women’s cancer control. Nigeria 
must ﬁ nd the political will to provide and coordinate 
resources in a sustainable way to reduce its burden of 
cervical and breast cancer.
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